GL1X · GenesisL1 explorer

MolNFT v1 · #70729 · protein

Enoyl-acp reductase from plasmodium falciparum (pfenr) in complex with triclosan variant T2

3LT1: “Enoyl-acp reductase from plasmodium falciparum (pfenr) in complex with triclosan variant T2”. X-ray diffraction, 2 ligands (NAD, FT2), 6 pockets (best druggability 0.82). MolNFT v1 #70729 on GenesisL1: 3D structure, binding sites…

PDB
3LT1
Type
protein
Length
577 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-acp reductase
EC
1.3.1.9
UniProt
Q9BJJ9
Ligands
NAD, FT2
Pockets
6 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-acp reductase (EC 1.3.1.9)protein28848% helix, 16% strandQ9BJJ9
BEnoyl-acp reductase (EC 1.3.1.9)protein28945% helix, 16% strandQ9BJJ9

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 2 copies · chains A, B
  • FT2 · 5-(chloromethyl)-2-(2,4-dichlorophenoxy)phenol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15540.820.8745NAD, FT2
25670.810.8748NAD, FT2
31830.570.8028empty
42040.560.7923empty
52700.540.7624empty

Interfaces

1 interface between chains.

  • A–B · 1658 Ų buried · 37 hydrogen bonds · protein-protein

Compared structures

  • 3LT1 · Enoyl-ACP Reductase from Plasmodium falciparum (PfENR) in complex with triclosan variant… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.